Wiener klinische Wochenschrift · 2024
[Position paper of the Austrian Society for Rheumatology and the Austrian Society for Pneumology on the diagnosis and treatment of sarcoidosis 2024].
Аннотация на английскомСтатьяConsensus StatementНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sterniste Georg, Hackner Klaus, Moazedi-Fürst Florentine, Grasl Marie, Idzko Marco, Shao Guangyu, Guttmann-Ducke Claudia, Talakić Emina, Prosch Helmut, Lohfink-Schumm Sylvia, Gabriel Michael, Lim Clarice, Hochreiter Johann, Bucher Brigitte, Böckle Barbara C, Kiener Hans Peter, Duftner Christina, Kastrati Kastriot, Rath Eva, Funk Marion, Löffler-Ragg Judith, Steinmaurer Monika, Kovacs Gabor, Verheyen Nicolas, Flick Holger, Antlanger Marlies, Traxler Gerhard, Tatscher Elisabeth, Zwick Ralf Harun, Lang David
Аннотация
In many cases sarcoidosis is a multisystemic disease that requires interdisciplinary medical cooperation in the diagnostics, treatment and medical care during follow-up. Due to the often chronic course, it is of utmost importance to include patients with their priorities and wishes at an early stage and extensively in disease management and to establish a shared decision making whenever possible. In the process of writing this joint position paper, the expert group on interstitial and orphan lung diseases of the Austrian Society for Pulmonology and the working group on rheumatological lung disorders of the Austrian Society for Rheumatology and Rehabilitation sought to include patient advocacy groups as well as experts for rare organ manifestations of sarcoidosis. This position paper is not only meant to reflect current scientific and clinical standards but should also focus the national expertise and by networking and exchange to be a first step to strengthen cooperation between stakeholders to ultimately improve care for patients with sarcoidosis.